Gene Query: KCNAB2

Dataset Description Geneva Score
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 90.05
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 68.22
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 53.08
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 50.7
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 50.7
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 49.92
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 48.14
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 48.1
ZIKV infection of monocytes activates inflammasome pathways 45.77
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 39.7
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 39.64
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 39.35
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 36.29
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 35.06
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 34.83
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 34.44
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 34.29
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 32.49
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 31.87
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 31.53
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 30.57
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 29.47
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 27.72
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 27.72
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 27.48
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 26.61
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 25.11
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 24.48
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 23.71
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 23.71
Effects of rFVIIIFc on human macrophages 23.62
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 23.09
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 23.09
circRNA-sequencing 23.03
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 23.02
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 22.6
Gene expression changes in human melanoma cell lines compared to primary melanocytes 22.54
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 22.07
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 21.3
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 21.2
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 20.96
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 20.9
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 20.54
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 20.23
The Glioma-Infiltrating T Cell Receptor Repertoire 20.21
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 20.13
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 20.03
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 20.03
NAPRT activation of macrophages 19.48
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 19.38
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 19.19
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 19.01
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 19.01
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 18.52
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 18.52
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 18.47
Proteomics identifies a marker signature of MAPKi resistance in melanoma 18.1
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 17.78
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 17.55
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 17.4
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 17.0
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 16.72
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 16.66
Total RNA-seq in ALL-SIL upon JQ1 inhibition 16.11
Intrahepatic MAIT cell gene expression revealed by RNA-seq 16.05
RNAseq of T-ALL upon long non coding rna purturbation 15.99
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 15.95
Global analysis of alternative splicing regulated by RBM10 15.7
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 15.49
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 15.47
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 15.26
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 15.2
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 15.19
RNA-seq of stable and unstable section of human atherosclerotic plaques 15.16
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 15.11
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 14.39
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 14.17
Transcriptional responses of melanoma cells to BRAF inhibition 14.03
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 14.02
MEIS1 regulates hematopoiesis in hPSCs 13.98
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 13.92
Chromatin-informed inference of transcriptional programs in gynecologic cancers 13.71
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 13.71
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 13.71
A novel target of EZH1/2 for treatment of mantle cell lymphoma 13.65
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 13.63
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 13.44
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 13.42
High-Throughput Kinetic Analysis of Fractional Killing 13.23
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 13.14
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 13.14
TGF-β promotes genomic instability after loss of RUNX3 13.01
RNA sequencing with KSHV infection and enrichment for circular RNAs 13.01
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 12.99
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 12.89
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 12.85
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 12.84
mRNA expression profile of Lymphocytes by high-throuput sequencing 12.78
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 12.72
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 12.63
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 12.61
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 12.61
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 12.6
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 12.47
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 12.42
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 12.42
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 12.39
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 12.26
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 12.26
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 12.15
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 12.13
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 12.02
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 12.02
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 12.01
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 12.01
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 11.82
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 11.74
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 11.67
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 11.63
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 11.62
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 11.61
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 11.44
Universal alternative splicing of noncoding exons 11.39
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 11.3
Control of prostate tumour growth by the long non-coding RNA GHSROS 11.12
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 11.11
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 11.04
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 11.03
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 10.95
UBC9 knockdown in bladder cancer T24 cell lines 10.94
Accurate annotation of human protein-coding small open reading frames 10.76
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 10.71
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 10.7
Generation and functional characterization of MDSC-like cells 10.68
Total RNA-seq in ALL-SIL upon TLX1 knockdown 10.66
Effect of FGF13 depletion on the H460 cell line 10.65
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 10.63
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 10.58
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 10.31
BCL11B 10.28
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 10.2
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 10.03
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 10.02
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 9.96
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 9.92
MYCi975 regulates MYC target genes 9.89
Repurposing of promoters and enhancers during mammalian evolution 9.81
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 9.7
Anti-inflammatory effect of indoleacrylic acid (IA) 9.56
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 9.56
Effect of PRDM11 depletion in U2932 cells 9.55
Transcriptomes of human monocytes after ex vivo exposure to uric acid 9.52
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 9.51
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.5
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 9.5
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 9.5
The effect of PPARG inhibition on human angiomyolipoma cells 9.49
SOX11 knockdown in B-ALL cell lines 9.39
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 9.31
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 9.3
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 9.25
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 9.19
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 9.16
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 9.16
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 9.13
Transcription elongation regulates genome 3D structure 9.13
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 9.09
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 9.03
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 9.01
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 8.95
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.92
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.92
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 8.79
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 8.78
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 8.78
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 8.74
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 8.7
A practical evaluation of alignment algorithms for RNA variant calling analysis 8.67
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.56
Landscape and variation of RNA secondary structure across the human transcriptome 8.5
Gene expression in GBM with Cav3.2 inhibition 8.35
A transcriptome dataset revealing the molecular features of breast cancer stem cells 8.28
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 8.25
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 8.25
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 8.17
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 8.17
MCF10A H-Ras RNA-Seq 8.14
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 8.11
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 8.1
hnRNP C is a key regulator of protein synthesis in mitosis 8.1
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 8.09
Reprogrammed myeloid cell transcriptomes in NSCLC 8.03
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 8.0
Peptidomimetic blockade of MYB in acute myeloid leukemia 8.0
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 7.99
Rorc disruption in human FG pancreatic cancer cells 7.98
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 7.97
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 7.96
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 7.96
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 7.9
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 7.9
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 7.88
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 7.88
Transcriptome of activated human and mouse MAIT cells 7.86
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 7.83
Short and Long RNA sequencing of human mature erythrocytes 7.83
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 7.82
Differentially expressed genes post knock down of lincDUSP26 7.76
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 7.75
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 7.74
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 7.74
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 7.71
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 7.66
MYC dependent mRNA translation shapes gene expression and cell biology 7.64
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 7.59
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 7.55
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 7.53
CircRNAome diversity in human mature B-cells, T-cells and monocytes 7.52
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.51
RNA-sequencing of formalin fixed human primary melanoma tissue 7.48
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 7.4
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.39
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 7.37
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 7.37
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 7.35
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 7.33
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 7.33
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 7.33
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.29
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 7.22
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 7.12
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 7.08
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 7.08
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 7.03
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 7.03
Alteration of the microRNA network during the progression of Alzheimer’s disease 6.99
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 6.93
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 6.93
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 6.9
Transcriptomic analysis of LSD1 6.88
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 6.86
Impact of dieldrin on transcription in Jurkat T cells 6.84
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 6.83
Landscape of H3K4me3 in human CD19 cells 6.82
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 6.8
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 6.8
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 6.79
The DNA methylation landscape of human melanoma [RNA-Seq] 6.77
The DNA methylation landscape of human melanoma 6.77
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 6.75
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 6.7
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 6.67
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.65
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 6.59
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 6.58
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 6.57
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 6.57
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 6.57
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 6.51
Generation of trichogenic adipose-derived stem cells by expression of three factors 6.46
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 6.44
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 6.44
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 6.42
Human cells contain natural double-stranded RNAs with potential regulatory capacity 6.34
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 6.34
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 6.29
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 6.27
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 6.27
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 6.23
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 6.21
H1609088 Human RNA-Sequencing 6.2
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 6.18
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 6.18
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 6.11
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.93
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.93
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 5.91
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 5.9
Identification of Sin3B regulated genes during quiescence 5.86
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 5.75
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 5.75
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.72
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 5.71
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 5.64
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 5.58
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 5.53
Tpl-2 small molecule project 5.49
Tpl-2 and MEK small molecule inhibitors 5.49
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 5.47
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 5.47
Loss of CREBBP results in gene expression repression in lymphoma cells 5.4
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 5.4
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 5.32
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 5.32
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 5.3
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 5.28
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 5.26
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 5.25
Efficient derivation of microglia-like cells from human pluripotent stem cells 5.16
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 5.15
Genome-wide identification of cancer-specific alternative splicing in circRNA 5.13
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 5.1
Gene expression profile difference among renal location in a stone former 5.09
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 5.08
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 5.05
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 5.03
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 5.03
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 5.01
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 5.0
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 4.97
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 4.97
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 4.96
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.94
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.89
nELAVL HITS-CLIP in Alzheimer's Disease patients 4.89
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 4.89
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 4.87
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.85
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 4.74
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 4.74
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 4.63
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 4.59
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 4.59
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 4.53
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 4.53
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 4.52
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 4.48
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 4.46
Transcriptional profile in human S. haematobium infection 4.42
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 4.39
In situ CAPTURE of chromatin interactions by biotinylated dCas9 4.39
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 4.39
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 4.34
Transcriptome analysis of peripheral blood monocytes 4.32
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 4.28
Widespread regulated alternative splicing of single codons accelerates proteome evolution 4.24
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 4.22
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 4.16
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.13
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 4.12
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.08
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.07
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 4.05
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 4.02
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 3.96
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 3.92
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 3.9
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 3.84
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.83
MARCKS and lnc-MARCKS act as inflammation regulators 3.79
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.78
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.73
Transcriptomic analysis of ERR alpha orphan nuclear receptor 3.73
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 3.66
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 3.64
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 3.63
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 3.63
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.54
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.54
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.51
SF3B1 Degron knockdown RNA-seq 3.42
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.33
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 3.31
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 3.26
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.24
RNA-Seq of the corpus callosum from 12 individuals 3.22
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 3.18
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 3.14
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 3.13
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 3.11
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 3.1
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.08
An acquired vulnerability of drug resistant melanoma with therapeutic potential 3.06
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 3.06
Impact on erythroid progenitor type on erythroid differntiation 3.05
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.05
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 3.0
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 2.97
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 2.97
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 2.97
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 2.96
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 2.91
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.88
RNA expression analysis upon JMJD1C depletion 2.88
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.85
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 2.8
Zika virus infection reprograms global transcription of host cells to allow sustained infection 2.79
Transcriptomes of oxLDL exposed trained monocytes 2.79
oxLDL exposed trained monocytes 2.79
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 2.72
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 2.71
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 2.68
RNA-seq data from human lymphoma cell lines 2.64
ChIP-seq and RNA-seq from human lymphoma cell lines 2.64
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 2.63
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.63
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.62
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 2.51
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.49
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 2.41
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.41
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.4
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.34
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 2.32
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 2.32
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 2.29
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 2.28
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 2.28
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.27
TAF1 is critical for AE driven leukemogenesis 2.27
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.26
Macrophage Ad5f35 PhenoMap 2.25
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.25
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 2.23
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 2.21
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.18
RNA-Seq and expression data from human adipose tissue 2.18
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.13
Gene expression analysis of human hepatocellular cancers 2.1
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 2.1
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.08
Transposon-based construction of strand-specific RNA-seq libraries 2.08
The age and genomic integrity of neurons after cortical stroke in humans 2.04
mRNA sequencing of oropharyngeal cancer cell lines 2.04
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.02
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.0
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.96
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.96
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 1.89
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 1.87
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.85
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.85
Human Treg IL-12 stimulation 1.84
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.79
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.67
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 1.64
Aging-associated patterns in the expression of human endogenous retroviruses 1.58
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.53
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.53
PRDM1 inhibits proliferation of human colon cancer organoids 1.53
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.49
CD74 role in transcription regulation [RNA-seq] 1.48
CD74 role in transcription regulation 1.48
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.37
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.31
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.31
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 1.22
Human optic chiasm from healthy controls and multiple sclerosis patients 1.21
Multiple sclerosis and EAE 1.21
Patient-derived xenograft platform for metastatic melanoma 1.19
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.19
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.16
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.14
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.13
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.1
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 1.05
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.04
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 1.03
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.02
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.99
The pioneer factor CEBPA modulates vitamin D signaling 0.89
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.89
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.82
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.81
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.74
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.69
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.67
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.66
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.62
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.56
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.55
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.54
The cytokine environment influence on human skin-derived T cells 0.5
MAIT cell RNA sequencing 0.49
MHC Transcriptomic landscape at haplotype-specific resolution 0.48
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.45
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.44
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.43
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.42
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.35
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.35
Gene expression analysis of breast cancer cell-lines 0.35
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.3
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.29
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.26
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.23
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.2
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.19
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.11
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.1
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.09
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.09
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.09
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.08
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.08
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.04
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.02
RNA-seq of primary patient AML samples 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation